Orencia Solution For Injection 125Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Orencia: Solution for injection (125mg)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ABATACEPT (a ba TA sept) is used to treat moderate to severe active rheumatoid arthritis or psoriatic arthritis in adults. This medicine is also used to treat juvenile idiopathic arthritis.

In-Depth Information

Orencia 125mg/ml Prefilled Syringe for Injection

NDC: 000032188
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis

Storage Information
Protect from light
Store in original package until time of use
Do not freeze
Refrigerate (between 36 and 46 degrees F)
Discard product if it contains particulate matter, is cloudy, or discolored
Orencia 125mg/ml Prefilled Syringe for Injection
Close All Sections Show

Reported Side Effects for Orencia 125mg/ml Prefilled Syringe for Injection

Close Show
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Antibody Formation Incidence:
<9.6%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
<2.6%*
Severity: MODERATE
Onset: EARLY
Bruise Incidence:
<2.5%*
Severity: MODERATE
Onset: EARLY
Itching Incidence:
<2.6%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Wheezing Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Cough Incidence:
<8.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
1.0-7.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
1.0-18.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
1.0-9.0%*
Severity: MILD
Onset: EARLY
New Primary Malignancy Incidence:
1.3%*
Severity: SEVERE
Onset: DELAYED
Flu Incidence:
5.0-13.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
5.0-13.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
5.0-13.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Infusion-related Reactions Incidence:
9.0%*
Severity: MODERATE
Onset: RAPID
Infection Incidence:
36.0-54.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
First Trimester

Class 6 - Unknown Risk

Second Trimester

Class 6 - Unknown Risk

Third Trimester

Class 6 - Unknown Risk

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Orencia

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.